Virtus LifeSci Biotech Products ETF

Top category "Fund Providers" is hidden please check in administration to make it visible

Virtus LifeSci Biotech Products ETF
  • Pininvest Analysis

About - Virtus Investment Partners VRTS/NASDAQ is a premier provider of investment solutions to individuals, financial advisors, and institutions. We aim to offer distinguished strategies and original perspectives to help our clients achieve better outcomes

Virtus ETF Solutions is an industry leader in subadvised exchange traded funds

Virtus LifeSci Biotech Products ETF  BBP/NYSEARCA invests in products stage companies, which are typically more established companies with much clinical trial failure risk behind them. They have already successfully completed multiple human clinical trials and have received FDA approval to sell and market a drug

LifeSci Index Partners, LLC is a New York-based index provider of healthcare-based stock market indices. The LifeSci team is comprised of investment professionals with experience in biotechnology equity research, in organic chemistry research in academia, and at pharmaceutical and biotechnology companies

Note from DATAvariance
The complete list of the 38 BBP constituents on the theme are not weighted; performance and volatility are calculated for informative purpose only - assuming one share of each component had been invested at the beginning of the selected period

For actual performance of the fund, which maybe higher or lower, depending on the weighting and trades decided by the provider, please check the information available on the Virtus LifeSci Biotech Products ETF site or contact your advisor

More about Virtus LifeSci Biotech Products ETF

Virtus LifeSci Biotech Products ETF • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Vol. Risk Contrib. MDD
 
ACADIA Pharmaceuticals Inc ACAD NASDAQ Health Care Drug Manufacturers - Diversified USD 39.34 6.1 B 74.0% 71%   7% -23%
Acorda Therapeutics Inc ACOR NASDAQ Health Care Biopharmaceuticals USD 2.10 101 M -86.8% 119%   0% -91%
Alexion Pharmaceuticals Inc. ALXN NASDAQ Health Care Biopharmaceuticals USD 105.27 23 B -13.3% 36%   2% -33%
Amgen Inc. AMGN NASDAQ Health Care Biopharmaceuticals USD 225.59 134 B 16.4% 21%   1% -16%
Biogen BIIB NASDAQ Health Care Biopharmaceuticals USD 278.14 50 B -17.4% 48%   1% -36%
BioMarin Pharmaceutical BMRN NASDAQ Health Care Biopharmaceuticals USD 86.15 15 B -9.7% 29%   2% -35%
Celgene CELG NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 108.24 77 B 23.5% 18%   1% -10%
Clovis Oncology, Inc. CLVS NASDAQ Health Care Biopharmaceuticals USD 8.93 489 M -63.5% 116%   2% -90%
Dynavax Technologies DVAX NASDAQ Health Care Biopharmaceuticals USD 5.78 485 M -47.7% 67%   2% -76%
Enanta Pharmaceuticals Inc ENTA NASDAQ Health Care Biopharmaceuticals USD 54.85 1.1 B -33.3% 41%   2% -48%
Exelixis EXEL NASDAQ Health Care Oncology USD 18.02 5.5 B -22.6% 39%   2% -39%
Gilead Sciences GILD NASDAQ Health Care Biopharmaceuticals USD 63.15 80 B -4.7% 21%   1% -12%
Halozyme Therapeutics HALO NASDAQ Health Care Biopharmaceuticals USD 19.07 2.8 B 15.1% 31%   3% -16%
Incyte Corporation INCY NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 76.74 17 B -4.0% 31%   2% -20%
Intercept Pharmaceuticals ICPT NASDAQ Health Care Biopharmaceuticals USD 96.65 3.2 B -19.2% 51%   2% -52%
Ionis Pharmaceuticals IONS NASDAQ Health Care Biopharmaceuticals USD 59.42 8.4 B 1.2% 38%   2% -37%
Ironwood Pharmaceuticals IRWD NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 12.37 1.9 B 14.0% 48%   2% -46%
Lexicon Pharmaceuticals LXRX NASDAQ Health Care Diabetes USD 3.36 357 M -24.7% 150%   4% -85%
Ligand Pharmaceuticals LGND NASDAQ Health Care Clinical trial work USD 88.54 1.6 B -22.9% 40%   2% -33%
Medicines Co MDCO NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 84.90 6.8 B 295.8% 47%   11% -18%
Momenta Pharmaceuticals MNTA NASDAQ Health Care Clinical trial work USD 28.18 2.8 B 143.4% 55%   9% -36%
Nektar Therapeutics NKTR NASDAQ Health Care Clinical trial work USD 21.13 3.7 B -51.9% 70%   1% -66%
Neurocrine Biosciences NBIX NASDAQ Health Care Biopharmaceuticals USD 99.17 9.1 B 9.7% 36%   3% -16%
Omeros Corp OMER NASDAQ Health Care Biopharmaceuticals USD 13.55 674 M 2.5% 50%   2% -37%
Portola Pharmaceuticals PTLA NASDAQ Health Care Biopharmaceuticals USD 13.65 1.1 B -49.9% 66%   2% -64%
Puma Biotechnology PBYI NASDAQ Health Care Biopharmaceuticals USD 8.10 316 M -69.8% 95%   1% -85%
Radius Health RDUS NASDAQ Health Care Biopharmaceuticals USD 18.85 870 M 3.6% 52%   3% -38%
Regeneron Pharmaceuticals REGN NASDAQ Health Care Biopharmaceuticals USD 345.28 38 B -17.5% 29%   2% -38%
Retrophin RTRX NASDAQ Health Care Biopharmaceuticals USD 16.32 701 M -21.3% 46%   2% -54%
Sarepta Therapeutics SRPT NASDAQ Health Care Gene Editing - Cell Therapies USD 112.39 8.4 B -8.4% 58%   3% -54%
Seattle Genetics Inc. SGEN NASDAQ Health Care Biopharmaceuticals USD 113.57 19 B 56.1% 43%   4% -22%
Spark Therapeutics ONCE NASDAQ Health Care Biopharmaceuticals USD 113.57 4.4 B 161.4% 82%   9% -16%
Theravance Biopharma TBPH NASDAQ Health Care Clinical trial work USD 26.19 1.5 B -5.1% 41%   2% -43%
United Therapeutics UTHR NASDAQ Health Care Biopharmaceuticals USD 89.33 3.9 B -22.9% 29%   1% -41%
Vanda Pharmaceuticals VNDA NASDAQ Health Care Drug Manufacturers - Diversified USD 14.29 762 M -52.0% 52%   1% -59%
Vertex Pharmaceuticals VRTX NASDAQ Health Care Biopharmaceuticals USD 229.06 59 B 20.9% 26%   2% -14%